See our media citations from outlets around the nation this week:
How Big Pharma is fighting Biden’s program to lower seniors’ drug costs (The Washington Post)
The legal challenges are part of a wider-ranging offensive by the pharmaceutical industry, long seen as one of the most powerful political forces in the nation’s capital. Since 2022, drugmakers and other companies have spent more than $761 million to lobby lawmakers and regulators, according to data from OpenSecrets, a money-in-politics watchdog.
Pressure rises on Biden, Democrats to reject AIPAC funds (Reuters)
A coalition of progressive groups is asking U.S. President Joe Biden and other Democratic Party officials to not accept endorsements or contributions from a pro-Israel group and its affiliated super PACs. Biden, a former vice president and senator, has long been a top recipient of the pro-Israel lobby, receiving over $5.2 million in support over the last 34 years, the most of any Congressional recipient, according to OpenSecrets.
Republicans Sell Boeing Stock as Crisis Deepens (Newsweek)
The financial relationship between Boeing and legislators works both ways. Indeed, the company spends millions lobbying politicians. According to campaign finance and lobbying aggregator OpenSecrets, which cited data from the Senate Office of Public Records, the company spent $14,420,000 on air transport lobbying ventures in 2023.